-
Spectranetics Selects Clinipace Worldwide to Manage Cardiovascular Device Clinical Study
Tuesday, July 19, 2011 - 9:02am | 257Clinipace Worldwide announced today that Spectranetics Corporation (Nasdaq: SPNC), a developer, manufacturer, marketer and distributer of single-use medical devices used in minimally invasive procedures within the cardiovascular system, has selected Clinipace to manage all aspects of a pivotal...
-
Robert W. Baird Upgrades NuVasive To Outperform
Tuesday, July 19, 2011 - 8:19am | 20Robert W. Baird has upgraded NuVasive (NASDAQ: NUVA) from Neutral to Outperform.
-
Benzinga's Top Upgrades
Tuesday, July 19, 2011 - 7:57am | 124Analysts at Kaufman Bros upgraded Aixtron SE (NASDAQ: AIXG) from “hold” to “buy.” AIXG's shares closed at $27.26 yesterday. Aixtron's trailing-twelve-month ROE is 38.76%. Analysts at Janney Montgomery Scott upgraded Talbots Inc (The) (NYSE: TLB) from “sell” to “neutral.” TLB's shares closed at $3....
-
Piper Jaffray Maintains ABAX Neutral Rating
Tuesday, July 19, 2011 - 7:34am | 94Piper Jaffray has issued a report maintaining a Neutral Rating on Abaxis (NASDAQ: ABAX) follwing a vet survey suggesting a stable market. According to the report, "Our survey uncovered a more optimistic 2H11 outlook, with median diagnostic testing volumes expected to increase 4.0%. We view initial...
-
Jefferies on Maintains Neutral On IDXX, $76 PT
Tuesday, July 19, 2011 - 7:17am | 101Jefferies has issued a report maintaining a Neutral Rating On IDEXX Laboratories (NASDAQ: IDXX) following a vet survey suggesting a stable market. According to Jefferies, "Encouragingly, our survey uncovered a more optimistic 2H11 outlook, with median diagnostic testing volumes expected to...
-
Bank of America Initiates IDEXX Laboratories At Buy, $90 PO
Tuesday, July 19, 2011 - 7:01am | 26Bank of America has initiated coverage on IDEXX Laboratories (NASDAQ: IDXX) with a Buy rating and $90 price objective.
-
Bank of America Initiates ABAXIS At Neutral, $30 PO
Tuesday, July 19, 2011 - 7:00am | 25Bank of America has initiated coverage on ABAXIS (NASDAQ: ABAX) with a Neutral rating and $30 price objective.
-
Alphatec Spine, Inc. Receives Japanese Regulatory Shonin Approval for Illico SE Posterior Fixation Percutaneous Screw System for Minimally Invasive Surgery
Monday, July 18, 2011 - 4:06pm | 95Alphatec Holdings, Inc. (Nasdaq: ATEC) today announces the Japanese launch of its Illico SE Posterior Fixation Percutaneous Screw System for minimally invasive surgery. The company recently received Shonin approval and will launch the system through its wholly owned subsidiary, Alphatec Pacific,...
-
Earnings Preview: Baxter International Earnings Expected to Increase Over Last Quarter
Monday, July 18, 2011 - 2:55pm | 560Baxter International (NYSE: BAX) earnings are coming up! Don't miss out: The company unveils its next round of earnings this Thursday, July 21, 2011. No time to prep before Thursday's announcement? Don't worry. Here is your everything-that-matters guide to Baxter International's second quarter...
-
Earnings Preview: Edwards Lifesciences Revenue Expected to Rise
Monday, July 18, 2011 - 2:55pm | 551It's time to gear up for Edwards Lifesciences (NYSE: EW) earnings! Keep your head in the game: The company releases its next round of earnings this Thursday, July 21, 2011. Want to skip the homework and get all the facts in one place? We thought so. Here is your everything-that-matters guide for...
-
6 Breakout Plays in a Sea of Red
Monday, July 18, 2011 - 11:35am | 224After the huge ramp up we saw in to Friday's close, it looked like we were setting up nicely for a potential rally this week, but if Monday is any indication of what lies for the week ahead, then it could be a royal disaster for the bulls out there. However, that doesn't mean that there aren't...
-
Bank of America Previews EMC Corp's 2Q earnings
Monday, July 18, 2011 - 9:41am | 139Bank of America has published a report on EMC Corp (NYSE: EMC) previewing 2Q earnings. In the report, Bank of America wrote, "Our quarterly EMC Value Add Resellers (VAR) survey points to a relatively solid C2Q11 (we believe channel is 40%+ of EMC sales), with revenue and EPS slightly ahead of...
-
Morgan Keenan Comments on AtriCure
Monday, July 18, 2011 - 8:36am | 105Morgan Keegan has published a report on AtriCure (NASDAQ: ATRC) after a grant to develop minimally invasive surgical technology. In the report, Morgan Keenan comments, "We think AtriCure shares are currently traded near fair value. Using a 10-year DCF and EV/Sales, AtriCure shares appear fairly...
-
Endologix and LeMaitre Vascular Enter Early Termination Agreement for European Distribution Rights of Endologix Products
Monday, July 18, 2011 - 8:30am | 201Accelerates Endologix's Transition to Direct Sales in Europe Supports LeMaitre's Strategy to Focus on Core Vascular Products Endologix, Inc. (Nasdaq: ELGX) and LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that the companies have entered into an early termination agreement for LeMaitre's...
-
Barclays Upgrades St. Jude Medical To Overweight
Monday, July 18, 2011 - 8:19am | 18Barclays has upgraded St. Jude Medical (NYSE: STJ) to Overweight.